jRCTs071180030CompletedNot Applicable
The evaluation of the effects of CAsein hydroLysate containing milk-derived peptides on Vascular function and blood pressure in subjects with Prehypertension (CALV-P study)
Not provided0 sites30 target enrollmentStarted: September 12, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 30
- Primary Endpoint
- -
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized Controlled Trial
- Intervention Model
- Crossover Assignment
- Primary Purpose
- Supportive Care
- Masking
- Single Blind
Eligibility Criteria
- Ages
- 30age old over to 75age old under (—)
- Sex
- All
Inclusion Criteria
- •Prehypertension (casual blood pressure = 120-139/80-89 mmHg)
Exclusion Criteria
- •Hypertension(casual blood pressure >140/90 mmHg)
- •Patients with cardiovascular disease
- •Allergy for milk
- •Atrial fibrillation
- •Current smoker
- •Taking food lowering blood pressure
Outcomes
Primary Outcomes
-
blood pressure
Secondary Outcomes
No secondary outcomes reported
Investigators
Similar Trials
Active, not recruiting
Not Applicable
C-PROWESS study (C-PROWESS study)Neo Ras Wild type metastatic colorectal cancerjRCTs03121056530
Completed
Not Applicable
CANTABILE study (CANTABILE study)T2DM patients with basic metabolic risksjRCTs051180112200
Recruiting
Not Applicable
VALINOR study (VALINOR study)Prostate cancerjRCTs05224022684
Recruiting
Not Applicable
Dia-NeP study (Dia-NeP study)Type 2 diabetes mellitusjRCTs0312406233,000
Recruiting
Not Applicable
PCCT studySolid tumorjRCTs032220618360